The Licensed One Wales Medicines Assessment Group (LOWMAG) is a sub-group of AWMSG and advises on existing and newly licensed medicines to enable patient access in the absence of technology appraisal advice from the National Institute for Health and Care Excellence (NICE). LOWMAG provides recommendations to AWMSG on licensed medicines when there is an unmet clinical need or an opportunity to add value. LOWMAG do this by considering the evidence of cost-effectiveness (when available), clinical effectiveness, budget impact and societal issues and take account of the views of clinicians, patients, patient support groups and the manufacturer of the medicine being assessed.
Download the LOWMAG Constitution.
LOWMAG meets up to 10 times a year in private, to talk about all the evidence for each medicine being assessed. At the meeting they will make a recommendation which will then be sent to AWMSG for endorsement. The Chair of LOWMAG is Professor James Coulson, Consultant Clinical Pharmacologist at Cardiff and Vale UHB and AWTTC's Clinical Director. Download the LOWMAG membership list.
All LOWMAG members have to fill in a Declaration of Interest form every year and before taking part in any LOWMAG meeting